Ingalls & Snyder LLC Gilead Sciences, Inc. Transaction History

Ingalls & Snyder LLC

$2.56 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 21, 2022	SELL	$59.54 - $68.01 $29,770 - $34,005	-500 Reduced 18.15%	2,255 $139,000
Q2 2022 Aug 11, 2022	SELL	$57.72 - $65.01 $57,720 - $65,010	-1,000 Reduced 26.63%	2,755 $170,000
Q4 2021 Feb 11, 2022	SELL	$64.88 - $73.64 $74,612 - $84,686	-1,150 Reduced 23.45%	3,755 $273,000
Q2 2021 Aug 03, 2021	SELL	$63.47 - $69.35 $27,863 - $30,444	-439 Reduced 8.21%	4,905 $338,000
Q1 2021 Apr 21, 2021	SELL	$60.0 - $68.46 $12,180 - $13,897	-203 Reduced 3.66%	5,344 $345,000
Q4 2020 Jan 27, 2021	SELL	$56.65 - $64.55 $109,051 - $124,258	-1,925 Reduced 25.76%	5,547 $323,000
Q3 2020 Oct 21, 2020	BUY	$62.1 - $78.08 $298,638 - $375,486	4,809 Added 180.59%	7,472 $472,000
Q2 2020 Jul 31, 2020	SELL	$72.34 - $84.0 $7,016 - $8,148	-97 Reduced 3.51%	2,663 $205,000
Q1 2020 Apr 22, 2020	SELL	$62.63 - $80.22 $31,315 - $40,110	-500 Reduced 15.34%	2,760 $206,000
Q4 2019 Jan 15, 2020	SELL	$61.62 - $67.78 $24,648 - $27,112	-400 Reduced 10.93%	3,260 $212,000
Q3 2019 Oct 16, 2019	SELL	$62.51 - $69.0 $312 - $345	-5 Reduced 0.14%	3,660 $232,000
Q2 2019 Jul 11, 2019	SELL	$61.87 - $69.38 $7.64 Million - $8.57 Million	-123,563 Reduced 97.12%	3,665 $248,000
Q1 2019 Apr 11, 2019	SELL	$62.53 - $70.05 $28,701 - $32,152	-459 Reduced 0.36%	127,228 $8.27 Million
Q4 2018 Jan 24, 2019	SELL	$60.54 - $79.0 $477,478 - $623,073	-7,887 Reduced 5.82%	127,687 $7.99 Million
Q3 2018 Oct 24, 2018	SELL	$71.28 - $78.92 $40,986 - $45,379	-575 Reduced 0.42%	135,574 $10.5 Million
Q2 2018 Aug 10, 2018	SELL	$64.88 - $75.68 $414,193 - $483,141	-6,384 Reduced 4.48%	136,149 $9.65 Million
Q1 2018 Apr 17, 2018	SELL	$72.84 - $88.8 $2.82 Million - $3.44 Million	-38,697 Reduced 21.35%	142,533 $10.7 Million
Q4 2017 Jan 19, 2018	BUY	$71.15 - $83.52 $12.9 Million - $15.1 Million	181,230	181,230 $13 Million

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

Black Rock Inc. New York, NY

121M
Shares

$11.1 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.7 Billion
0.18% of portfolio
Capital World Investors Los Angeles, CA

76.5M
Shares

$7.07 Billion
1.03% of portfolio
Capital Research Global Investors Los Angeles, CA

61.8M
Shares

$5.71 Billion
1.12% of portfolio
State Street Corp Boston, MA

60.2M
Shares

$5.56 Billion
0.21% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ingalls & Snyder LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ingalls & Snyder LLC with notifications on news.

Account